PROCEPT BioRobotics Corporation (PRCT) Tops Q1 EPS by 112c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q1 EPS of $0.56, $1.12 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $83.13 million versus the consensus estimate of $80.5 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• RBC Capital Downgrades Hermes International (RMS:FP) (HESAY) to Sector Perform
• PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti,